NHS rolls out world-first DNA blood test to personalise cancer treatment
The Guardian - 29-May-2025New liquid biopsy accelerates targeted cancer treatment
Join the club for FREE to access the whole archive and other member benefits.
Clinical Senior Lecturer at Newcastle University
Dr. Alastair Greystoke is a Clinical Senior Lecturer at Newcastle University and an Honorary Consultant Medical Oncologist at the Northern Centre for Cancer Care, Freeman Hospital. He specializes in lung cancer, particularly in developing new anti-cancer drugs and advancing personalized medicine.
Dr. Greystoke co-leads the Sir Bobby Robson Early Clinical Trials Centre, focusing on early-phase drug trials for thoracic malignancies. He also leads the Pharmacodynamic Biomarker team at Newcastle University, aiming to improve cancer treatment precision.
Visit website: https://www.ncl.ac.uk/medical-sciences/people/profile/alastairgreystoke.html
See also
Public world-class research-intensive University based in the North East of England
Details last updated 03-Jun-2025
New liquid biopsy accelerates targeted cancer treatment